Advertisement

Latest News

​​NEPTUNE and CureGN Driving Precision Nephrology Forward, With Alessia Fornoni, MD, PhD

3 hours ago

NEPTUNE and CureGN are advancing precision nephrology, linking molecular data to outcomes and enabling targeted therapies and smarter clinical trial design.

The Future of CAR-T in Lupus Nephritis Treatment, With Brad Rovin, MD

7 hours ago

CAR-T therapy in lupus may shift earlier in care, but challenges in access, logistics, and patient selection remain as the field moves toward precision treatment.

The Search for Answers in FSGS Recurrence, With Priya Verghese, MBBS (MD), MPH

10 hours ago

FSGS recurrence threatens transplant success, yet clinicians still lack reliable predictors, mechanisms, and effective prevention strategies.

Sustained PASI Responses Observed Through Week 60 with Zasocitinib, With Melinda Gooderham, MD

11 hours ago

New late-breaking phase 3 data suggest zasocitinib may help reshape the oral treatment landscape for moderate-to-severe plaque psoriasis.

FFR Angiography Noninferior to Pressure-Wire Strategy in CAD Analysis, With William Fearon, MD

12 hours ago

Fearon discusses results from the ALL-RISE trial, which demonstrated the FFRangio’s efficacy in assessing lesions for patients with coronary artery disease.

Advertisement
Advertisement